Skip to main content

Assessment of ARIA Sufficiency: Ebglyss (lebrikizumab)

    Basic Details
    Approval Date
    Friday, September 13, 2024
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes